Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease

Blood
Christian Philipp PallaschClemens-Martin Wendtner

Abstract

Resistance toward apoptotic stimuli mediated by overexpression of antiapoptotic factors or extracellular survival signals is considered to be responsible for accumulation of malignant B cells in chronic lymphocytic leukemia (CLL). TOSO was identified as overexpressed candidate gene in CLL, applying unit-transformation assays of publicly available microarray datasets. Based on CLL samples from 106 patients, TOSO was identified to exhibit elevated relative expression (RE) of 6.8 compared with healthy donor B cells using quantitative real-time polymerase chain reaction (PCR; P = .004). High levels of TOSO expression in CLL correlated with high leukocyte count, advanced Binet stage, previous need for chemotherapy, and unmutated IgV(H) status. CD38(+) CLL subsets harboring proliferative activity showed enhanced TOSO expression. We evaluated functional mechanisms of aberrant TOSO expression and identified TOSO expression significantly induced by B-cell receptor (BCR) stimulation compared with control cells (RE; 8.25 vs 4.86; P = .01). In contrast, CD40L signaling significantly reduced TOSO expression (RE, 2.60; P = .01). In summary, we show that the antiapoptotic factor TOSO is associated with progressive disease and enhanced in the ...Continue Reading

References

Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F Caligaris-Cappio, T J Hamblin
Mar 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Peter ChuThomas J Kipps
May 25, 2002·Seminars in Cancer Biology·Paolo GhiaFederico Caligaris-Cappio
Feb 14, 2004·Blood·Freda K Stevenson, Federico Caligaris-Cappio
Mar 30, 2004·The Hematology Journal : the Official Journal of the European Haematology Association·Daniela de ToteroMarco Gobbi
Feb 16, 2005·The Journal of Clinical Investigation·Bradley T MessmerNicholas Chiorazzi
Sep 17, 2005·Proceedings of the National Academy of Sciences of the United States of America·Amelia CimminoCarlo M Croce

❮ Previous
Next ❯

Citations

Jan 26, 2011·Medical Oncology·Veysel Sabri HancerMelih Aktan
Jan 30, 2013·Proceedings of the National Academy of Sciences of the United States of America·Karl S LangTak W Mak
Oct 28, 2009·The Journal of Experimental Medicine·Hiromi KubagawaJi-Yang Wang
Jan 1, 2010·International Immunology·Hideaki ShimaHiroshi Ohno
May 6, 2014·Journal of Clinical Immunology·Hiromi KubagawaKazuhito Honjo
Jan 9, 2014·Proceedings of the National Academy of Sciences of the United States of America·Dirk BrennerTak W Mak
Apr 7, 2009·Leukemia & Lymphoma·Christian Philipp Pallasch, Clemens Martin Wendtner
Feb 13, 2010·Expert Opinion on Therapeutic Targets·Monica Lopez-Guerra, Dolors Colomer
Jul 12, 2012·Expert Review of Hematology·Maria Teresa Scupoli, Giovanni Pizzolo
Sep 8, 2010·Seminars in Cancer Biology·Graham Packham, Freda Stevenson
Aug 26, 2009·Scandinavian Journal of Immunology·G H S RichterS Burdach
Jul 30, 2010·International Journal of Cancer. Journal International Du Cancer·Lukas P FrenzelClemens-Martin Wendtner
Dec 30, 2014·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy·Yoshiki KubagawaHiromi Kubagawa
Jul 8, 2016·Journal of Neurochemistry·Laura Planells-FerrerJoan X Comella
Jun 19, 2016·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Eyad AlhouraniThomas Liehr
Feb 21, 2018·The Journal of Clinical Investigation·Jinbo YuKyeong-Hee Lee
Jul 16, 2019·Journal of Leukocyte Biology·Rebecca Blandino, Nicole Baumgarth
Feb 20, 2020·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Ling-Sai ChangHo-Chang Kuo
May 7, 2019·Frontiers in Immunology·Sanae Ben MkaddemRenato C Monteiro
Sep 13, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bérengère VireAdrian Wiestner
May 28, 2019·Frontiers in Immunology·Hiromi KubagawaPeter K Jani
Apr 11, 2019·Frontiers in Immunology·Jun LiuJi-Yang Wang
Mar 19, 2021·Blood·Laura BeckmannLukas P Frenzel
Aug 31, 2021·EBioMedicine·Jared M AndrewsJacqueline E Payton

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis